GE HEALTHCARE TECHNOLOGIES INC. Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
GE HEALTHCARE TECHNOLOGIES INC. (GEHC) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of $2.15 billion for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-02-04
- GE HEALTHCARE TECHNOLOGIES INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was $602.00M, a 18.43% decline year-over-year.
- GE HEALTHCARE TECHNOLOGIES INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2024-12-31 was $738.00M, a 77.40% increase year-over-year.
- GE HEALTHCARE TECHNOLOGIES INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2024-09-30 was $490.00M, a 26.94% increase year-over-year.
- GE HEALTHCARE TECHNOLOGIES INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2023-12-31 was $416.00M, a 26.63% decline year-over-year.
- GE HEALTHCARE TECHNOLOGIES INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2025 was $2.15B, a 5.07% increase from fiscal 2024.
- GE HEALTHCARE TECHNOLOGIES INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2024 was $2.05B, a 26.70% increase from fiscal 2023.
- GE HEALTHCARE TECHNOLOGIES INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2023 was $1.62B, a 16.98% decline from fiscal 2022.
- GE HEALTHCARE TECHNOLOGIES INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2022 was $1.95B, a 14.33% decline from fiscal 2021.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2025-12-31 | $602.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $2.15B 10-K · filed 2026-02-04 | ||
| 2025-09-30 | $1.55B 10-Q · filed 2025-10-29 | |||
| 2024-12-31 | $738.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $1.23B derived: sum of 2 quarters · filed 2026-02-04 | $2.05B 10-K · filed 2026-02-04 | |
| 2024-09-30 | $490.00M 10-Q · filed 2024-10-30 | $1.31B 10-Q · filed 2025-10-29 | ||
| 2023-12-31 | $416.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $802.00M derived: sum of 2 quarters · filed 2026-02-04 | $1.24B derived: sum of 3 quarters · filed 2026-02-04 | $1.62B 10-K · filed 2026-02-04 |
| 2023-09-30 | $386.00M 10-Q · filed 2024-10-30 | $819.00M derived: sum of 2 quarters · filed 2024-10-30 | $1.20B 10-Q · filed 2024-10-30 | |
| 2023-06-30 | $433.00M 10-Q · filed 2023-07-25 | $816.00M 10-Q · filed 2023-07-25 | ||
| 2022-12-31 | $567.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $1.06B derived: sum of 2 quarters · filed 2025-02-13 | $1.55B derived: sum of 3 quarters · filed 2025-02-13 | $1.95B 10-K · filed 2025-02-13 |
| 2022-09-30 | $493.00M 10-Q · filed 2023-10-31 | $979.00M derived: sum of 2 quarters · filed 2023-10-31 | $1.38B 10-Q · filed 2023-10-31 | |
| 2022-06-30 | $486.00M 10-Q · filed 2023-07-25 | $888.00M 10-Q · filed 2023-07-25 | ||
| 2021-12-31 | $2.27B 10-K · filed 2024-02-06 |